August 02, 2019

DHVI Receives 2019 Outstanding Research Partners Award

Congratulations to the Duke Vaccine Trial Unit (DVTU) and the DHVI Accessioning Unit for receiving the “2019 Outstanding Research Partners Award” from Duke Early Phase Clinical Research (DEPRU), an extension of the Duke Clinical Research Institute. The DVTU was honored for excellence and collaboration in teamwork and shared resources for the Duke Vaccine and Treatment Evaluation Unit (VTEU) studies and the DHVI Accessioning Unit Core for excellence in processing whole blood samples in a Phase 1 Clinical Trial investigating idiopathic pulmonary arterial hypertension in support of DEPRU.